Highlights and Quick Summary
- Long-term assets (Other) for the quarter ending June 30, 2023 was $2.32 Million (a 0.09% increase compared to previous quarter)
- Year-over-year quarterly Long-term assets (Other) increased by 0.26%
- Annual Long-term assets (Other) for 2022 was $2.32 Million (a 0.35% increase from previous year)
- Annual Long-term assets (Other) for 2021 was $2.31 Million (a 0.43% increase from previous year)
- Annual Long-term assets (Other) for 2020 was $2.3 Million (a 1104.71% increase from previous year)
Visit stockrow.com/DYN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Long-term assets (Other) of Dyne Therapeutics, Inc.
Most recent Long-term assets (Other)of DYN including historical data for past 10 years.Interactive Chart of Long-term assets (Other) of Dyne Therapeutics, Inc.
Dyne Therapeutics, Inc. Long-term assets (Other) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $2.32 | $2.32 | – | – | – |
| 2022 | $2.32 | $2.32 | $2.32 | $2.31 | $2.32 |
| 2021 | $2.31 | $2.31 | $2.89 | $2.3 | $2.31 |
| 2020 | – | – | $2.3 | $0.19 | $2.3 |
| 2019 | $0.19 | – | – | – | $0.19 |
Business Profile of Dyne Therapeutics, Inc.
Sector: Healthcare
Industry: Biotechnology